Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial
  2. Bonnett,Tyler; Potter, Gail E; Dodd, Lori E
  3. Clinical Trials (London, England). 2025, Feb 08; 17407745251313928.
  1. 2.   Knowing the signs: a direct and generalizable motivation of two-sided tests
  2. Rice, Kenneth; Bonnett,Tyler; Krakauer, Chloe
  3. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY. 2019, Dec 26;
  1. 3.   Adaptive evolution of the matrix extracellular phosphoglycoprotein in mammals
  2. Machado, J. P.; Johnson, W. E.; O'Brien, S. J.; Vasconcelos, V.; Antunes, A.
  3. Bmc Evolutionary Biology. 2011, Nov; 11
  1. 4.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 5.   Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits
  2. Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Sarafandi, A. A.; Mickiene, D.; Groll, A. H.; Sein, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005, MAY; 49(5): 2084-2092.
  1. 6.   Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests
  2. Ogino, S.; Flodman, P.; Wilson, R. B.; Gold, B.; Grody, W. W.
  3. Genetics in Medicine. 2005, MAY-JUN; 7(5): 317-327.
  1. 7.   Automation of NMR structure determination of proteins
  2. Altieri, A. S.; Byrd, R. A.
  3. Current Opinion in Structural Biology. 2004, OCT; 14(5): 547-553.
  1. 8.   Efficacy of PLD-118, a novel inhibitor of Candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and Esophageal candidiasis caused by fluconazole-resistant C albicans
  2. Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Sarafandi, A. A.; Sein, T.; Mickiene, D.; Bacher, J.; Groll, A. H.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2004, OCT; 48(10): 3959-3967.
  1. 9.   Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA
  2. Donoghue, H. D.; Spigelman, M.; Greenblatt, C. L.; Lev-Maor, G.; Bar-Gal, G. K.; Matheson, C.; Vernon, K.; Nerlich, A. G.; Zink, A. R.
  3. Lancet Infectious Diseases. 2004, SEP; 4(9): 584-592.
  1. 10.   Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening
  2. Ogino, S.; Wilson, R. B.; Gold, B.; Hawley, P.; Grody, W. W.
  3. Genetics in Medicine. 2004, SEP-OCT; 6(5): 439-449.
  1. 11.   Mechanism of Differential Catalytic Efficiency of Two Polymorphic Forms of Human Glutathione S-Transferase P1-1 in the Glutathione Conjugation of Carcinogenic Diol Epoxide of Chrysene
  2. Hu, X.; Ji, X. H.; Srivastava, S. K.; Xia, H.; Awasthi, S.; Nanduri, B.; Awasthi, Y. C.; Zimniak, P.; Singh, S. V.
  3. Archives of Biochemistry and Biophysics. 1997 345(1): 32-38.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel